CN114107348A - Chlamydomonas reinhardtii-based protein interaction analysis method - Google Patents
Chlamydomonas reinhardtii-based protein interaction analysis method Download PDFInfo
- Publication number
- CN114107348A CN114107348A CN202111405561.6A CN202111405561A CN114107348A CN 114107348 A CN114107348 A CN 114107348A CN 202111405561 A CN202111405561 A CN 202111405561A CN 114107348 A CN114107348 A CN 114107348A
- Authority
- CN
- China
- Prior art keywords
- target protein
- chlamydomonas reinhardtii
- ble
- tag
- strep
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000195597 Chlamydomonas reinhardtii Species 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title claims abstract description 23
- 230000006916 protein interaction Effects 0.000 title claims abstract description 9
- 238000012482 interaction analysis Methods 0.000 title claims abstract description 8
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 83
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 65
- 230000014509 gene expression Effects 0.000 claims abstract description 11
- 108010006654 Bleomycin Proteins 0.000 claims abstract description 10
- 229960001561 bleomycin Drugs 0.000 claims abstract description 10
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 claims abstract description 10
- 230000004927 fusion Effects 0.000 claims abstract description 10
- 238000004458 analytical method Methods 0.000 claims abstract description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 5
- 239000013598 vector Substances 0.000 claims description 19
- 239000012634 fragment Substances 0.000 claims description 13
- 101150055499 lov-1 gene Proteins 0.000 claims description 13
- 239000013604 expression vector Substances 0.000 claims description 9
- 102000003960 Ligases Human genes 0.000 claims description 7
- 108090000364 Ligases Proteins 0.000 claims description 7
- 108010030074 endodeoxyribonuclease MluI Proteins 0.000 claims description 7
- 238000001976 enzyme digestion Methods 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 5
- 101150038738 ble gene Proteins 0.000 claims description 3
- 210000002421 cell wall Anatomy 0.000 claims description 3
- 230000002018 overexpression Effects 0.000 claims description 3
- 230000002950 deficient Effects 0.000 claims description 2
- 238000003556 assay Methods 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 108010033276 Peptide Fragments Proteins 0.000 abstract description 3
- 102000007079 Peptide Fragments Human genes 0.000 abstract description 3
- 238000001514 detection method Methods 0.000 abstract description 2
- 230000008054 signal transmission Effects 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 21
- 239000013612 plasmid Substances 0.000 description 16
- 108020004414 DNA Proteins 0.000 description 14
- 239000002609 medium Substances 0.000 description 10
- 238000010586 diagram Methods 0.000 description 9
- 239000000499 gel Substances 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 230000002319 phototactic effect Effects 0.000 description 8
- 238000000246 agarose gel electrophoresis Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 230000009466 transformation Effects 0.000 description 7
- 241000195493 Cryptophyta Species 0.000 description 6
- 108020001507 fusion proteins Proteins 0.000 description 6
- 102000037865 fusion proteins Human genes 0.000 description 6
- 108091026890 Coding region Proteins 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 5
- 210000003763 chloroplast Anatomy 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000001262 western blot Methods 0.000 description 5
- 239000006180 TBST buffer Substances 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 101100178679 Caenorhabditis elegans hsp-1 gene Proteins 0.000 description 3
- 101100018009 Drosophila melanogaster Hsp70Aa gene Proteins 0.000 description 3
- 101100507660 Drosophila melanogaster Hsp70Ab gene Proteins 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 244000153158 Ammi visnaga Species 0.000 description 2
- 235000010585 Ammi visnaga Nutrition 0.000 description 2
- 108091006146 Channels Proteins 0.000 description 2
- 108091000080 Phosphotransferase Proteins 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 102000001253 Protein Kinase Human genes 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 108700019146 Transgenes Proteins 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 2
- 229940013640 flavin mononucleotide Drugs 0.000 description 2
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 description 2
- 239000011768 flavin mononucleotide Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 230000029553 photosynthesis Effects 0.000 description 2
- 238000010672 photosynthesis Methods 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108060006633 protein kinase Proteins 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 235000019231 riboflavin-5'-phosphate Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101100029886 Caenorhabditis elegans lov-1 gene Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 108010035848 Channelrhodopsins Proteins 0.000 description 1
- 102000034573 Channels Human genes 0.000 description 1
- 102000005927 Cysteine Proteases Human genes 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 102100037840 Dehydrogenase/reductase SDR family member 2, mitochondrial Human genes 0.000 description 1
- 241000701832 Enterobacteria phage T3 Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- -1 PSAD terminator Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108010081996 Photosystem I Protein Complex Proteins 0.000 description 1
- 101710188053 Protein D Proteins 0.000 description 1
- 101710132893 Resolvase Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 241000723792 Tobacco etch virus Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108010084455 Zeocin Proteins 0.000 description 1
- QRSFFHRCBYCWBS-UHFFFAOYSA-N [O].[O] Chemical compound [O].[O] QRSFFHRCBYCWBS-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 238000010296 bead milling Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000029264 phototaxis Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012419 revalidation Methods 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 108091005957 yellow fluorescent proteins Proteins 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/405—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from algae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8209—Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a chlamydomonas reinhardtii-based protein interaction analysis method. According to the method, a resistance gene Shble and a target protein are subjected to fusion expression in Chlamydomonas reinhardtii, a flexible peptide fragment affinity Tag 12 XHis is inserted between the Sh ble and the target protein, a Strep II Tag is inserted into a carboxyl terminal of the target protein, a positive clone strain screened by bleomycin is cultured in a large scale, and the target protein and related proteins interacted with the target protein are simultaneously purified by utilizing a Strep II Tag affinity column. The method can be extended to the analysis and detection of all Chlamydomonas reinhardtii protein signal transmission channels.
Description
Technical Field
The invention belongs to the technical field of molecular biology, and relates to a chlamydomonas reinhardtii-based protein interaction analysis method.
Background
Chlamydomonas reinhardtii is a model organism widely studied at present and is the only species which can realize nucleus transformation, chloroplast transformation and mitochondria transformation simultaneously. The method is a favorite research object of scientists in the fields of photosynthesis, reproductive science, plant biotechnology, chloroplast transformation technology and the like. Chlamydomonas reinhardtii is a haploid eukaryotic alga, has two flagella and a chloroplast, and normally moves to an area most suitable for growth by controlling phototaxis through sensing the intensity of green light in the environment by a light channel protein (channelrhodopsin). In the nuclear transformation process, the exogenous gene is integrated in the nuclear genome of Chlamydomonas reinhardtii in a non-homologous recombination manner. Although widely studied, scientists have been lacking means for stable expression of foreign genes in Chlamydomonas reinhardtii.
The Sh ble gene is a resistance gene of bleomycin and can be used as a selective marker in Chlamydomonas reinhardtii. In Chlamydomonas reinhardtii, the Ble protein protects cells by binding antibiotics into the nucleus, and thus its expression level is proportional to the tolerance level of antibiotics.
LOV is a domain of plant phototactics. Phototactics are composed of two LOV domains and one kinase domain. The major function of the luciferin in higher plants is to control chloroplasts. The LOV domain belongs to a family of numerous members, most of which are light(s) ((LLight), oxygen (Oxygen) and voltage (vVoltage). It contains a non-covalently bound Flavin Mononucleotide (FMN) chromophore, which under irradiation with blue light binds to a serine residue and initiates a conformational change in the domain, which, when placed in the dark, returns the LOV domain through a series of conformational changes to the original energy state. In higher plants, phototactics are generally responsible for sensing the intensity of blue light in ambient light. When excited, the LOV structural domain is changed in conformation, so that protein kinase at the carboxyl terminal is activated, and then downstream protein is modified through the kinase, so that a signal transduction process is completed. The function of the phototactic element in the higher plants is mainly to control the movement of chloroplast in the leaf, realize the maximum photosynthesis under the weak light and avoid the damage of free radicals generated by over-irradiation under the strong light. Although homologous to phototactics in higher plants, phototactics in Chlamydomonas reinhardtii are apparentDoes not perform the same function as higher plant phototactic elements. Its LOV domain is highly homologous to that of higher plants, but there are large non-conserved insertions in the key active regions of its kinase domain.
Disclosure of Invention
The invention aims to provide a chlamydomonas reinhardtii-based protein interaction analysis method.
The technical scheme for realizing the purpose of the invention is as follows:
the chlamydomonas reinhardtii-based protein interaction analysis method specifically comprises the following steps: the Sh ble and the target protein of the resistance gene are fused and expressed in Chlamydomonas reinhardtii, a flexible peptide fragment affinity Tag 12 XHis is inserted between the Sh ble and the target protein, Strep II Tag is inserted at the carboxyl terminal of the target protein, the positive clone strains screened by bleomycin are cultured in a large scale, and the target protein and related proteins which interact with the target protein are simultaneously purified by utilizing a Strep II Tag affinity column.
The method for fusion expression of the resistance gene Sh ble and the target protein in Chlamydomonas reinhardtii comprises the following steps: constructing a fusion expression vector of the Sh ble gene and the target protein, carrying out enzyme digestion linearization on the fusion expression vector, and transferring the linearized DNA into Chlamydomonas reinhardtii.
The target protein of the invention can be any Chlamydomonas reinhardtii protein, and in the specific embodiment of the invention, the Chlamydomonas reinhardtii protein is LOV1 structural domain of a phototactic protein.
The chlamydomonas reinhardtii disclosed by the invention is a chlamydomonas reinhardtii strain sensitive to bleomycin, and comprises but is not limited to a cell wall defect type overexpression mutant strain UVM 4.
The invention relates to a method for fusion expression of a resistance gene Sh ble and a target protein in Chlamydomonas reinhardtii, which comprises the following steps:
(1) PCR amplifying target protein DNA, using EcoRI and MluI to respectively enzyme-cut the target protein DNA fragment and the PCYX009 vector, and connecting through T4 ligase to obtain a vector inserted with target protein DNA-Strep II tag;
(2) respectively carrying out enzyme digestion on Sh ble and a vector inserted with target protein DNA-Strep II tag by NdeI and AgeI, and connecting the Sh ble and the vector by T4 ligase to obtain an expression vector inserted with Shble-target protein DNA-Strep II tag;
(3) using a fast-cutting enzyme KpnI to carry out enzyme digestion on the expression vector inserted with the Sh ble-target protein DNA-Strep II tag to obtain linear DNA;
(4) the linear DNA was transferred to Chlamydomonas reinhardtii and positive clones were screened using bleomycin.
Compared with the prior art, the invention has the following advantages:
aiming at the problem that exogenous recombinant genes are difficult to express in chlamydomonas reinhardtii bodies, the invention utilizes fusion expression of a resistance gene Sh ble and target protein and inserts a flexible peptide fragment affinity tag 12 XHis between the Sh ble and the target protein, thereby not interfering the correct folding of the target protein. And (2) inserting Strep II Tag into the carboxyl terminal of the target protein, purifying the related protein interacted with the target protein by utilizing the high specificity of the Strep II Tag, and further purifying the target protein by utilizing a 12 × His Tag to realize the identification of the target protein interaction group. The method of the invention does not need additional screening markers, greatly reduces the screening workload of the transformant, and over 90 percent of monoclone growing on the selective TAP plate expresses the target exogenous gene. The method can be extended to the analysis and detection of almost all Chlamydomonas reinhardtii protein signal transmission channels.
Drawings
FIG. 1 is a schematic diagram of the structure of plasmid PCYX 009.
FIG. 2 is a diagram showing the result of PCR agarose gel electrophoresis of the Sh ble nucleic acid coding sequence.
FIG. 3 is a photograph of the results of PCR agarose gel electrophoresis of the LOV1-Strep II tag nucleic acid coding sequence.
FIG. 4 is a diagram showing the results of double-restriction agarose gel electrophoresis of EcoRI and MluI of PCYX009 plasmid.
FIG. 5 is a graph showing the results of double restriction enzyme digestion of EcoRI and MluI of plasmid PCY009(LOVI-Strep II tag) after large fragment ligation of LOVI-Strep II tag and vector PCY 009.
FIG. 6 is a diagram showing the electrophoresis results of a large-fragment agarose gel of a vector digested by plasmid PCY009(LOVI-Strep II tag) NdeI and AgeI in two ways.
FIG. 7 is a diagram showing the results of colony PCR verification of plasmid PCY0010 after double digestion of Sh ble with vector PCY009(LOVI-Strep II tag) NdeI and AgeI and large fragment ligation.
FIG. 8 is a graph showing the results of double restriction of NdeI and AgeI in plasmid PCY0010 after double restriction of Sh ble and vector PCY009(LOVI-Strep II tag) NdeI and AgeI together with the ligated large fragment.
FIG. 9 shows the transformants grown by the bead milling method of vector PCY0010 onto a zeocin antibiotic-containing plate.
FIG. 10 is a western blot validation chart of transformants.
FIG. 11 is a schematic diagram of the structure of the PCYX0010 plasmid.
FIG. 12 is a SDS-PAGE and western blot validation of the Sh ble-LOV1 fusion protein after purification.
FIG. 13 is a scheme showing the purification and enrichment of Sh ble-LOV1 fusion protein and a protein interacting with LOV1 protein.
Detailed Description
The invention will be further described with reference to specific embodiments and figures, but is not limited thereto. The procedures, conditions, reagents, experimental methods and the like for carrying out the present invention are general knowledge and common general knowledge in the art except for the contents specifically mentioned below, and the present invention is not particularly limited.
The materials used in the examples are as follows:
1. the source of algal strain
The Chlamydomonas reinhardtii strain selected is a cell wall-deficient overexpression mutant strain UVM4(Ralph Bock, MPIMP).
2. Source of plasmids
Reference to the construction of the PCYX009 plasmid [ chen guiqi. hyper-folding wiener yellow fluorescent protein and its study and analysis of expression in chlamydomonas reinhardtii [ D ]. university of tokyo chem, 2020 ], contains the elements in sequence from N-terminus to C-terminus: PSAD (photosystem I protein D) promoter, cloning site of target gene, PSAD terminator, HSP70A promoter, continuous promoter RBCS2 (ribose biphosphate carboxylase small chain 2), resistance selection gene APHVIII, and RBCS2 stop codon. The promoter of RBCS2 of Chlamydomonas reinhardtii can drive the high-efficiency expression of transgenes, and when the first intron of RBCS2 is added to the upstream or downstream of the promoter, the transformation efficiency and the expression level of endogenous and exogenous genes are remarkably improved. The HSP70A promoter (bacteriophage T7 promoter) can be used as a transcription activator, and when the promoter of RBCS2 is placed downstream of the HSP70A promoter, the expression level of chlamydomonas reinhardtii transgene is further increased. The cloning site of the target gene sequentially comprises a ribosome binding site, an NdeI sequence CCATGG and an AgeI site ACCGGT from the N end to the C end; 12 histidine sites and a tobacco etch virus cysteine protease cleavage site GAGAACCTGTACTTCCAATCC; MluI cleavage site ACGCGT and EcoRI cleavage site GAATTC and the stop codon TAG. The PCYX009 plasmid (FIG. 1) and Shble (SEQ ID NO.1) and LOVI sequences are shown in the sequence table (SEQ ID NO. 2).
3. Source of primers
The synthetic primers were all from Biotechnology, Inc. of Ongbenaceae, Beijing.
4. Primary reagent
Tryptone, yeast extract, NaCl, Tris-baes were purchased from Sigma; restriction endonucleases, phusion enzymes, were purchased from Thermo Fisher; rTaq enzyme, T4 ligase, was purchased from Takara. The plasmid miniprep kit and the gel recovery kit were purchased from Axygen corporation. NTP, DEPC water and RNase inhibitor were purchased from Shanghai Biotechnology Limited.
Construction of PCYX0010 vector
a) Cloning of Sh ble and LOV1 genes
Based on the comparison of the codon used by Sh ble and LOV1 with the usage frequency of Escherichia coli codon in Kazusa online database (http:// www.kazusa.or.jp/codon /), a novel Sh ble coding sequence (SEQ ID NO.1) and a LOVI coding sequence (SEQ ID NO.2) were designed and synthesized. And then amplified by a PCR method. The PCR reaction system configuration is shown in Table 1.
TABLE 1 PCR reaction System preparation Table
Sh ble Forward primer(SEQ ID NO.4):5’-cccatatgactagtatggccaggatg-3’;
Sh ble Reverse primer(SEQ ID NO.5):5’-gaccggtgtcctgctcctcg-3’;
LOV1 Forward primer(SEQ ID NO.6):5’-cgacgcgtatgaccttcgtggtggc-3’;
LOV1 Reverse primer(SEQ ID NO.7):5’- cggaattcttacttctcgaactgggggtggctccaggtcttgctggtca-3’。
The PCR results are shown in FIGS. 2 and 3. The length of the target segment Sh ble is 387bp, and the optimal annealing temperature is 50 ℃. The target fragment LOV1-Strep II tag is 348bp in length, and the optimal annealing temperature is 64 ℃.
b) Recovering target DNA, cutting target fragments LOV1-Strep II tag and PCYX009 vector with EcoRI and MluI enzyme, performing agarose gel electrophoresis, and recovering cut products as shown in FIG. 4; the recovered target fragment and the PCYX009 vector fragment were ligated with T4 ligase at a molar ratio of 4:1 for 2 hours at 22 ℃.
c) The above ligation products were transformed into 80uL DH 5. alpha. competent cells by heat shock at 42 ℃, added with 700uL LB medium and then placed on a shaker at 37 ℃ and cultured at 200 rpm for 45 minutes.
d) Centrifuging the bacterial liquid at the rotating speed of 125000 rpm for 1 minute, and then sucking 700uL of supernatant; after the remaining medium was gently aspirated by a pipette, the medium was spread on an LB solid plate containing ampicillin, and the plate was placed upside down in an incubator at 37 ℃ and cultured for 12 hours.
e) A single colony of the plate was picked, and after a small amount of amplification, a recombinant plasmid was extracted and designated PCY009(LOVI-Strep II tag). The extracted plasmid was double digested with EcoRI and MluI, identified by agarose gel electrophoresis, and identified as correct by sequencing, as shown in FIG. 5.
f) Digesting the Sh ble of the target fragment and the PCY009(LOVI-Strep II tag) with NdeI and AgeI, and then performing agarose gel electrophoresis, as shown in FIG. 6, and recovering the digested product; the recovered desired fragment LOV1 and the large vector fragment cut with fast-cutting enzymes NdeI and AgeI were ligated at 22 ℃ for 2 hours with T4 ligase at a molar ratio of 4: 1. The obtained expression vector containing the target gene LOV1 is named as PCYX0010, the coding sequence is SEQ ID NO.3, and the structural schematic diagram of the plasmid is shown in FIG. 11. FIG. 7 is a diagram showing the results of PCR verification of the PCYX0010 colony. FIG. 8 is a diagram showing the results of double-restriction agarose gel electrophoresis of plasmid PCYX0010 with NdeI and AgeI.
Transformation of PCYX0010
a) Chlamydomonas reinhardtii strain UVM4 culture
Picking a monoclonal algal strain with toothpick in solid TAP medium, transferring into liquid TAP medium (TAP liquid medium (see www.chlamy.org): Tris base 20ml/L, phosphor buffer 10ml/L, Nutrient stock 10ml/L, Trace elements1ml/L, adjusting pH to 7.1-7.4 with glacial acetic acid, fixing volume, autoclaving, and storing), and 16h red and blue light (50% red light, 50% blue light, 6.0 × 10) at 22 deg.C19Photon/m.)/8h dark, 120rpm, as OD600Inoculating 1ml of algae solution into 50ml of fresh TAP culture medium when the culture medium is 0.2-0.4, and continuing culturing until the Chlamydomonas reinhardtii grows to logarithmic phase (OD)6000.8-1.0).
b) The vector pCYX0010 was digested with the fast-cutting enzyme KpnI for about 2ug 3-4h, and the linear plasmid was stored in a refrigerator at-20 ℃ for further use.
c) When Chlamydomonas reinhardtii grows to logarithmic growth phase (OD)6000.8-1.0), placing into a 50ml centrifuge tube, centrifuging at room temperature at 1,350rcf for 5min, discarding the supernatant, and fully suspending with the unspent TAP. 2ug of linearized DNA, 100ul of 20% PEG (polyethylene glycol) and a well-suspended algal solution (total volume not exceeding 300ul) were added to a 2ml centrifuge tube containing 300mg of glass beads with radius 0.6-0.8um treated with HCl. Maximum shaking speed vortex 15s, transferred to 50ml fresh TAP medium, incubated for 12-18h at 22 ℃ in the dark at 120 rpm. Put into a 50ml centrifuge tube, centrifuged at 1,350g for 7min at normal temperature, and the supernatant was discarded. After the suspension was fully and uniformly suspended by the remaining TAP, the algal solution transferred into the vector pCYX0010 was uniformly spread on a TAP plate containing 10. mu.g/ml bleomycin, incubated in the dark for 12 hours, and then cultured at 22 ℃ under light for 1-2 weeks, so that a monoclonal algal strain appeared, as shown in FIG. 9.
Screening of PCYX0010 Positive clones
a) 8 monoclonal algae strains and a wild type strain of wild type UVM4 were randomly picked with toothpicks in solid TAP medium as a secondary control and inoculated into 50ml TAP medium at 22 ℃ for 16h of red blue light (50% red light, 50% blue light, 6.0X 10)19Photon/m.)/8h dark, 120 rpm. Grow to OD600At 0.8, 2ml of algal solution was collected, centrifuged at 12000rcf for 1 minute at room temperature, and the supernatant was discarded. 125ul of PBS (phosphate buffer saline) is added to the precipitate for uniform suspension, 125ul of 2 Xloading buffer (SDS-PAGE) is added for uniform mixing, denaturation is carried out at 95 ℃ for 10min, the mixture is incubated on ice for 1min, centrifugation is carried out at 12,000g for 1min at normal temperature, and 20ul of supernatant is taken for sampling.
Table 212% SDS-PAGE formulation
Name of reagent | Separating glue (ml) | Concentrated glue (ml) |
ddH2O | 1.7 | 1.525 |
30% gel stock solution | 2.0 | 0.325 |
4 Xgel buffer | 1.25 | 0.625 |
10%SDS | 0.05 | 0.025 |
10%APS | 0.05 | 0.025 |
TEMED | 0.01 | 0.005 |
b) Two SDS-PAGE gels are assembled in an electrophoresis device, buffer solution is filled in the electrophoresis device, the gel is run at a constant voltage of 90V in a refrigerator at 4 ℃, when a sample runs to the junction position of the stacking gel and the separating gel, the voltage value is adjusted to be 120V, when the sample runs to a proper position, a power supply is turned off, the SDS-PAGE is taken down, one SDS-PAGE gel is used for quantification, and the other SDS-PAGE gel is used for western blot verification.
Screening of Western blot Positive clones
a) SDS-PAGE glue is assembled into a film transferring device according to a spongy cushion, 3 layers of filter paper, glue, an NC film, 3 layers of filter paper and the spongy cushion, and is filled with buffer solution.
b) Transferring into membrane at constant current of 300mA for 60min in refrigerator, turning off power supply, washing with TBST for 30s, sealing with 5% skimmed milk powder for 1.5h, and washing with TBST for 5min for 3 times.
c) Incubate primary antibody (Anti-6 × His antibody) overnight at 4 deg.C, wash 3 times with TBST, 5min each time; secondary antibody (HRP-conjugated Goat Anti-Rabbit IgG) was added, incubated at room temperature for 1.5h, and washed 3 times with TBST for 5min each.
d) And spreading the luminous liquid on the NC film, and taking a picture. The results are shown in FIG. 10.
7. Positive clone resistance gene gradient screening and mass culture
a) Preparing TAP agar plate with bleomycin 10ug/ml, 20ug/ml and 50ug/ml, screening positive clone strain in three resistant gradient plates, and screening out the most resistant monoclonal strain.
b) The most resistant positive clone was inoculated into 50ml TAP medium at 22 deg.C for 16h red and blue light (50% red light, 50% blue light, 6.0X 10)19Photon/m.)/8h dark, 120 rpm. Grow to OD600Inoculating the bacterial liquid to 1L TAP culture medium for large-scale culture until OD is about 0.6600The culture is stopped when the growth reaches about 0.8-1.0.
c) Cooling at 4 deg.C, centrifuging the algae liquid at 4 deg.C and 8000g for 30min, discarding the supernatant, washing the precipitate with ddH2O, centrifuging again, discarding the supernatant, weighing the algae, and freezing at-80 deg.C.
Enrichment and purification of Shble-LOV1 fusion protein and determination of potential related proteins
a) Taking out the precipitate from a refrigerator at-80 deg.C, inserting into ice for redissolving, suspending the algae body with buffer W, adding appropriate amount of PMSF, and crushing the algae body with an ultrasonic crusher.
b) Centrifuging the broken bacteria liquid in a high-speed refrigerated centrifuge at 4 deg.C and 18000g for 20min, removing uncrushed organelles and cell debris in the precipitate, filtering the supernatant with 0.22ul microporous membrane, and inserting on ice to prepare a hanging column.
c) The Strep II Tag gravity column was equilibrated to 5 bed volumes with buffer W, then the protein sample was loaded with a peristaltic pump, cycled 2 times, and then equilibrated to 5 bed volumes with buffer W.
d) And (3) eluting the protein on the Strep II Tag gravity column by buffer BXT, wherein 0.5ml is used as one elution unit volume, the elution work of the protein can be completed after 6 units of elution, and most of protein samples exist in the first 3 elution units.
f) 20ul of protein sample was taken from the first 3 elution groups, 20ul of 2 Xloading buffer (SDS-PAGE) was added and mixed well, denatured at 95 ℃ for 10min, incubated on ice for 1min, centrifuged at 12000rcf for 1min at room temperature, and 20ul of supernatant was taken for loading. Wild type served as negative control for this experiment.
e) Two groups of SDS-PAGE gels were run, one for quantification and one for western blot re-validation, as shown in FIG. 12, the Sh ble-LOV1 fusion protein was positioned at 27.9kDa, and since the purification Tag Strep II Tag was at the C-terminus of LOV1, only Sh ble-LOV1 fusion protein was purified by the Strep II Tag gravity column, and at the same time, the protein interacting with LOV1 protein was also purified, while LOV1 was an endogenous protein of Chlamydomonas reinhardtii, Sh ble was an exogenous protein, and therefore the other purified proteins were basically proteins with potential interaction with LOV 1. The purification and enrichment procedures for the Sh ble-LOV1 fusion protein and the protein interacting with the LOV1 protein are shown in FIG. 13.
Sequence listing
<110> Nanjing university of science and technology
<120> Chlamydomonas reinhardtii-based protein interaction analysis method
<141> 2021-11-24
<160> 7
<170> SIPOSequenceListing 1.0
<210> 1
<211> 387
<212> DNA
<213> Streptococcus indians (Streptococcus ichussinundastus)
<400> 1
actagtatgg ccaggatggc caagctgacc agcgccgtgc ccgtgctgac cgcccgcgac 60
gtggccggcg ccgtggagtt ctggaccgac cgcctgggct tcagccgcga cttcgtggag 120
gacgacttcg ccggcgtggt gcgcgacgac gtgaccctgt tcatcagcgc cgtgcaggac 180
caggtggtgc ccgacaacac cctggcctgg gtgtgggtgc gcggcctgga cgagctgtac 240
gccgagtgga gcgaggtggt gagcaccaac ttccgcgacg ccagcggccc cgccatgacc 300
gagatcggcg agcagccctg gggccgcgag ttcgccctgc gcgaccccgc cggcaactgc 360
gtgcacttcg tggccgagga gcaggac 387
<210> 2
<211> 324
<212> DNA
<213> Chlamydomonas reinhardtii (Chlamydomonas reinhardtii)
<400> 2
atgaccttcg tggtggccga cgccaccctg cccgactgcc ccctggtgta cgccagcgag 60
ggcttctacg ccatgaccgg ctacggcccc gacgaggtgc tgggccacaa ctgccgcttc 120
ctgcagggcg agggcaccga ccccaaggag gtgcagaaga tccgcgacgc catcaagaag 180
ggcgaggcct gcagcgtgcg cctgctgaac taccgcaagg acggcacccc cttctggaac 240
ctgctgaccg tgacccccat caagaccccc gacggccgcg tgagcaagtt cgtgggcgtg 300
caggtggacg tgaccagcaa gacc 324
<210> 3
<211> 6994
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
ggtacccagc ttttgttccc tttagtgagg gttaattgcg cgcttggcgt aatcatggtc 60
atagctgttt cctgtgtgaa attgttatcc gctcacaatt ccacacaaca tacgagccgg 120
aagcataaag tgtaaagcct ggggtgccta atgagtgagc taactcacat taattgcgtt 180
gcgctcactg cccgctttcc agtcgggaaa cctgtcgtgc cagctgcatt aatgaatcgg 240
ccaacgcgcg gggagaggcg gtttgcgtat tgggcgctct tccgcttcct cgctcactga 300
ctcgctgcgc tcggtcgttc ggctgcggcg agcggtatca gctcactcaa aggcggtaat 360
acggttatcc acagaatcag gggataacgc aggaaagaac atgtgagcaa aaggccagca 420
aaaggccagg aaccgtaaaa aggccgcgtt gctggcgttt ttccataggc tccgcccccc 480
tgacgagcat cacaaaaatc gacgctcaag tcagaggtgg cgaaacccga caggactata 540
aagataccag gcgtttcccc ctggaagctc cctcgtgcgc tctcctgttc cgaccctgcc 600
gcttaccgga tacctgtccg cctttctccc ttcgggaagc gtggcgcttt ctcatagctc 660
acgctgtagg tatctcagtt cggtgtaggt cgttcgctcc aagctgggct gtgtgcacga 720
accccccgtt cagcccgacc gctgcgcctt atccggtaac tatcgtcttg agtccaaccc 780
ggtaagacac gacttatcgc cactggcagc agccactggt aacaggatta gcagagcgag 840
gtatgtaggc ggtgctacag agttcttgaa gtggtggcct aactacggct acactagaag 900
gacagtattt ggtatctgcg ctctgctgaa gccagttacc ttcggaaaaa gagttggtag 960
ctcttgatcc ggcaaacaaa ccaccgctgg tagcggtggt ttttttgttt gcaagcagca 1020
gattacgcgc agaaaaaaag gatctcaaga agatcctttg atcttttcta cggggtctga 1080
cgctcagtgg aacgaaaact cacgttaagg gattttggtc atgagattat caaaaaggat 1140
cttcacctag atccttttaa attaaaaatg aagttttaaa tcaatctaaa gtatatatga 1200
gtaaacttgg tctgacagtt accaatgctt aatcagtgag gcacctatct cagcgatctg 1260
tctatttcgt tcatccatag ttgcctgact ccccgtcgtg tagataacta cgatacggga 1320
gggcttacca tctggcccca gtgctgcaat gataccgcga gacccacgct caccggctcc 1380
agatttatca gcaataaacc agccagccgg aagggccgag cgcagaagtg gtcctgcaac 1440
tttatccgcc tccatccagt ctattaattg ttgccgggaa gctagagtaa gtagttcgcc 1500
agttaatagt ttgcgcaacg ttgttgccat tgctacaggc atcgtggtgt cacgctcgtc 1560
gtttggtatg gcttcattca gctccggttc ccaacgatca aggcgagtta catgatcccc 1620
catgttgtgc aaaaaagcgg ttagctcctt cggtcctccg atcgttgtca gaagtaagtt 1680
ggccgcagtg ttatcactca tggttatggc agcactgcat aattctctta ctgtcatgcc 1740
atccgtaaga tgcttttctg tgactggtga gtactcaacc aagtcattct gagaatagtg 1800
tatgcggcga ccgagttgct cttgcccggc gtcaatacgg gataataccg cgccacatag 1860
cagaacttta aaagtgctca tcattggaaa acgttcttcg gggcgaaaac tctcaaggat 1920
cttaccgctg ttgagatcca gttcgatgta acccactcgt gcacccaact gatcttcagc 1980
atcttttact ttcaccagcg tttctgggtg agcaaaaaca ggaaggcaaa atgccgcaaa 2040
aaagggaata agggcgacac ggaaatgttg aatactcata ctcttccttt ttcaatatta 2100
ttgaagcatt tatcagggtt attgtctcat gagcggatac atatttgaat gtatttagaa 2160
aaataaacaa ataggggttc cgcgcacatt tccccgaaaa gtgccacact aaattgtaag 2220
cgttaatatt ttgttaaaat tcgcgttaaa tttttgttaa atcagctcat tttttaacca 2280
ataggccgaa atcggcaaaa tcccttataa atcaaaagaa tagaccgaga tagggttgag 2340
tgttgttcca gtttggaaca agagtccact attaaagaac gtggactcca acgtcaaagg 2400
gcgaaaaacc gtctatcagg gcgatggccc actacgtgaa ccatcaccct aatcaagttt 2460
tttggggtcg aggtgccgta aagcactaaa tcggaaccct aaagggagcc cccgatttag 2520
agcttgacgg ggaaagccgg cgaacgtggc gagaaaggaa gggaagaaag cgaaaggagc 2580
gggcgctagg gcgctggcaa gtgtagcggt cacgctgcgc gtaaccacca cacccgccgc 2640
gcttaatgcg ccgctacagg gcgcgtccca ttcgccattc aggctgcgca actgttggga 2700
agggcgatcg gtgcgggcct cttcgctatt acgccagctg gcgaaagggg gatgtgctgc 2760
aaggcgatta agttgggtaa cgccagggtt ttcccagtca cgacgttgta aaacgacggc 2820
cagtgagcgc gcgtaatacg actcactata gggcgaattg gagctccacc gcggtggcgg 2880
ccgctctaga actagtggat cccacacacc tgcccgtctg cctgacagga agtgaacgca 2940
tgtcgaggga ggcctcacca atcgtcacac gagccctcgt cagaaacacg tctccgccac 3000
gctctccctc tcacggccga ccccgcagcc cttttgccct ttcctaggcc accgacagga 3060
cccaggcgct ctcagcatgc ctcaacaacc cgtactcgtg ccagcggtgc ccttgtgctg 3120
gtgatcgctt ggaagcgcat gcgaagacga aggggcggag caggcggcct ggctgttcga 3180
agggctcgcc gccagttcgg gtgcctttct ccacgcgcgc ctccacacct accgatgcgt 3240
gaaggcaggc aaatgctcat gtttgcccga actcggagtc cttaaaaagc cgcttcttgt 3300
cgtcgttccg agacatgtta gcagatcgca gtgccacctt tcctgacgcg ctcggcccca 3360
tattcggacg caattgtcat ttgtagcaca attggagcaa atctggcgag gcagtaggct 3420
tttaagttgc aaggcgagag agcaaagtgg gacgcggcgt gattattggt atttacgcga 3480
cggcccggcg cgttagcggc ccttccccca ggccagggac gattatgtat caatattgtt 3540
gcgttcgggc actcgtgcga gggctcctgc gggctgggga gggggatctg ggaattggag 3600
gtacgaccga gatggcttgc tcggggggag gtttcctcgc cgagcaagcc agggttaggt 3660
gttgcgctct tgactcgttg tgcattctag gaccccactg ctactcacaa caagccatat 3720
gactagtatg gccaggatgg ccaagctgac cagcgccgtg cccgtgctga ccgcccgcga 3780
cgtggccggc gccgtggagt tctggaccga ccgcctgggc ttcagccgcg acttcgtgga 3840
ggacgacttc gccggcgtgg tgcgcgacga cgtgaccctg ttcatcagcg ccgtgcagga 3900
ccaggtggtg cccgacaaca ccctggcctg ggtgtgggtg cgcggcctgg acgagctgta 3960
cgccgagtgg agcgaggtgg tgagcaccaa cttccgcgac gccagcggcc ccgccatgac 4020
cgagatcggc gagcagccct ggggccgcga gttcgccctg cgcgaccccg ccggcaactg 4080
cgtgcacttc gtggccgagg agcaggacac cggtcaccac caccaccacc accaccacca 4140
ccaccaccac gagaacctgt acttccaggg cacgcgtatg accttcgtgg tggccgacgc 4200
caccctgccc gactgccccc tggtgtacgc cagcgagggc ttctacgcca tgaccggcta 4260
cggccccgac gaggtgctgg gccacaactg ccgcttcctg cagggcgagg gcaccgaccc 4320
caaggaggtg cagaagatcc gcgacgccat caagaagggc gaggcctgca gcgtgcgcct 4380
gctgaactac cgcaaggacg gcaccccctt ctggaacctg ctgaccgtga cccccatcaa 4440
gacccccgac ggccgcgtga gcaagttcgt gggcgtgcag gtggacgtga ccagcaagac 4500
ctggagccac ccccagttcg agaagtaaga attctggcag cagctggacc gcctgtacca 4560
tggagaagag ctttacttgc cgggatggcc gatttcgctg attgatacgg gatcggagct 4620
cggaggcttt cgcgctaggg gctaggcgaa gggcagtggt gaccagggtc ggtgtggggt 4680
cggcccacgg tcaattagcc acaggaggat cagggggagg taggcacgtc gacttggttt 4740
gcgaccccgc agttttggcg gacgtgctgt tgtagatgtt agcgtgtgcg tgagccagtg 4800
gccaacgtgc cacacccatt gagaagacca accaacttac tggcaatatc tgccaatgcc 4860
atactgcatg taatggccag gccatgtgag agtttgccgt gcctgcgcgc gccccggggg 4920
cggggggggg acgggtgggg ggtagggggt ctcacgggaa cagcacgcta ggggtcaggg 4980
gggggggggg gcgcagttta gctgaccagc cgtgggatga tgcacgcatt tgcaaggaca 5040
gggtaatcac agcagcaaca tggtgggctt aggacagctg tgggtcagtg gacggacggc 5100
aggggaggga cggcgcagct cgggagacag ggggagacag cgtgactgtg cacatcaagc 5160
ttatcgatac cgtcgaccct cgagcgggga gctcgctgag gcttgacatg attggtgcgt 5220
atgtttgtat gaagctacag gactgatttg gcgggctatg agggcgcggg aagctctgga 5280
agggccgcga tggggcgcgc ggcgtccaga aggcgccata cggcccgctg gcggcaccca 5340
tccggtataa aagcccgcga ccccgaacgg tgacctccac tttcagcgac aaacgagcac 5400
ttatacatac gcgactattc tgccgctata cataaccact cagctagctt aagatcccat 5460
caagcttgca tgccgggcgc gccagaagga gcgcagccaa accaggatga tgtttgatgg 5520
ggtatttgag cacttgcaac ccttatccgg aagccccctg gcccacaaag gctaggcgcc 5580
aatgcaagca gttcgcatgc agcccctgga gcggtgccct cctgataaac cggccagggg 5640
gcctatgttc tttacttttt tacaagagaa gtcactcaac atcttaaaat ggccaggtga 5700
gtcgacgagc aagcccggcg gatcaggcag cgtgcttgca gatttgactt gcaacgcccg 5760
cattgtgtcg acgaaggctt ttggctcctc tgtcgctgtc tcaagcagca tctaaccctg 5820
cgtcgccgtt tccatttgca ggatggccac tccgccctcc ccggtgctga agaatttcga 5880
agcatggacg atgcgttgcg tgcactgcgg ggtcggtatc ccggttgtga gtgggttgtt 5940
gtggaggatg gggcctcggg ggctggtgtt tatcggcttc ggggtggtgg gcgggagttg 6000
tttgtcaagg tggcagctct gggggccggg gtgggcttgt tgggtgaggc tgagcggctg 6060
gtgtggttgg cggaggtggg gattcccgta cctcgtgttg tggagggtgg tggggacgag 6120
agggtcgcct ggttggtcac cgaagcggtt ccggggcgtc cggccagtgc gcggtggccg 6180
cgggagcagc ggctggacgt ggcggtggcg ctcgcggggc tcgctcgttc gctgcacgcg 6240
ctggactggg agcggtgtcc gttcgatcgc agtctcgcgg tgacggtgcc gcaggcggcc 6300
cgtgctgtcg ctgaagggag cgtcgacttg gaggatctgg acgaggagcg gaaggggtgg 6360
tcgggggagc ggcttctcgc cgagctggag cggactcggc ctgcggacga ggatctggcg 6420
gtttgccacg gtcacctgtg cccggacaac gtgctgctcg accctcgtac ctgcgaggtg 6480
accgggctga tcgacgtggg gcgggtcggc cgtgcggacc ggcactccga tctcgcgctg 6540
gtgctgcgcg agctggccca cgaggaggac ccgtggttcg ggccggagtg ttccgcggcg 6600
ttcctgcggg agtacgggcg cgggtgggat ggggcggtat cggaggaaaa gctggcgttt 6660
taccggctgt tggacgagtt cttctgaggg acctgatggt gttggtggct gggtagggtt 6720
gcgtcgcgtg ggtgacagca cagtgtggac gttgggatcc ccgctccgtg taaatggagg 6780
cgctcgttga tctgagcctt gccccctgac gaacggcggt ggatggaaga tactgctctc 6840
aagtgctgaa gcggtagctt agctccccgt ttcgtgctga tcagtctttt tcaacacgta 6900
aaaagcggag gagttttgca attttgttgg ttgtaacgat cctccgttga ttttggcctc 6960
tttctccatg ggcgggctgg gcgtatttga agcg 6994
<210> 4
<211> 26
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
cccatatgac tagtatggcc aggatg 26
<210> 5
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
gaccggtgtc ctgctcctcg 20
<210> 6
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
cgacgcgtat gaccttcgtg gtggc 25
<210> 7
<211> 49
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
cggaattctt acttctcgaa ctgggggtgg ctccaggtct tgctggtca 49
Claims (6)
1. The chlamydomonas reinhardtii-based protein interaction analysis method is characterized by comprising the following specific steps of: the Sh ble and the target protein of the resistance gene are fused and expressed in Chlamydomonas reinhardtii, a flexible peptide section affinity Tag 12 XHis is inserted between the Sh ble and the target protein, a carboxyl section of the target protein is inserted into Strep II Tag, a positive clone strain screened by bleomycin is cultured in a large scale, and the target protein and related protein which interacts with the target protein are simultaneously purified by utilizing a Strep II Tag affinity column.
2. The analysis method according to claim 1, wherein the fusion expression method of the Sh ble resistance gene and the target protein in Chlamydomonas reinhardtii comprises the following steps: constructing a fusion expression vector of the Sh ble gene and the target protein, carrying out enzyme digestion linearization on the fusion expression vector, and transferring the linearized DNA into Chlamydomonas reinhardtii.
3. The assay of claim 1, wherein the target protein is the LOV1 domain.
4. The assay of claim 1, wherein the Chlamydomonas reinhardtii is a bleomycin-sensitive Chlamydomonas reinhardtii species.
5. The assay of claim 1, wherein the Chlamydomonas reinhardtii is a cell wall-deficient overexpression mutant strain UVM 4.
6. The analysis method according to claim 2, wherein the fusion expression method of the resistance gene Shble and the target protein in Chlamydomonas reinhardtii specifically comprises the following steps:
(1) PCR amplifying target protein DNA, using EcoRI and MluI to respectively enzyme-cut the target protein DNA fragment and the PCYX009 vector, and connecting through T4 ligase to obtain a vector inserted with target protein DNA-Strep II tag;
(2) respectively carrying out enzyme digestion on Sh ble and a vector inserted with the target protein DNA-Strep II tag by NdeI and AgeI, and connecting the Sh ble and the vector by T4 ligase to obtain an expression vector inserted with the Sh ble-target protein DNA-Strep II tag;
(3) using a fast-cutting enzyme KpnI to carry out enzyme digestion on the expression vector inserted with the Sh ble-target protein DNA-Strep II tag to obtain linear DNA;
(4) the linear DNA was transferred to Chlamydomonas reinhardtii and positive clones were screened using bleomycin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111405561.6A CN114107348A (en) | 2021-11-24 | 2021-11-24 | Chlamydomonas reinhardtii-based protein interaction analysis method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111405561.6A CN114107348A (en) | 2021-11-24 | 2021-11-24 | Chlamydomonas reinhardtii-based protein interaction analysis method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114107348A true CN114107348A (en) | 2022-03-01 |
Family
ID=80372230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111405561.6A Pending CN114107348A (en) | 2021-11-24 | 2021-11-24 | Chlamydomonas reinhardtii-based protein interaction analysis method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114107348A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102181471A (en) * | 2011-03-23 | 2011-09-14 | 深圳大学 | Method for constructing secretory expression carrier and secretory expression system of Chlammydomonas reinhardtii |
CN111848766A (en) * | 2019-04-28 | 2020-10-30 | 南京理工大学 | Hyper-folding Venus yellow fluorescent protein and expression thereof in Chlamydomonas reinhardtii |
-
2021
- 2021-11-24 CN CN202111405561.6A patent/CN114107348A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102181471A (en) * | 2011-03-23 | 2011-09-14 | 深圳大学 | Method for constructing secretory expression carrier and secretory expression system of Chlammydomonas reinhardtii |
CN111848766A (en) * | 2019-04-28 | 2020-10-30 | 南京理工大学 | Hyper-folding Venus yellow fluorescent protein and expression thereof in Chlamydomonas reinhardtii |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107686848A (en) | The stable of transposons collaboration CRISPR/Cas9 systems knocks out single plasmid vector and its application | |
CN109021111B (en) | Gene base editor | |
CN110079551B (en) | Circular RNA expression vector and construction method and application thereof | |
CN109735480B (en) | Recombinant bacillus subtilis for synthesizing lactyl-N-neotetraose and construction method and application thereof | |
CN111378785A (en) | Pseudo virus standard substance for nucleic acid diagnosis of novel coronavirus 2019-nCov and application thereof | |
CN109810958B (en) | Saffron-derived CCD2 mutant, coding sequence and application thereof, and recombinant yeast strain for producing crocetin | |
CN109825465A (en) | Recombined bacillus subtilis and its construction method and application based on the balance UDP- sugar supply synthesis new tetrose of lactoyl-N- | |
IL171903A (en) | Purification of her-2 variants | |
CN110257403B (en) | Infectious laryngotracheitis virus gB gene expression, recombinant fowlpox virus thereof, construction method and application | |
CN113754783B (en) | Application of recombinant RLK in plant immune regulation | |
US6365344B1 (en) | Methods for screening for transdominant effector peptides and RNA molecules | |
CN114107348A (en) | Chlamydomonas reinhardtii-based protein interaction analysis method | |
CN100591771C (en) | Hypoxia response elements gene treating plasmid and its constructing method | |
CN113354718A (en) | Piranin precursor, expression cassette and preparation method thereof | |
CN101397570B (en) | Intermediate vector for gene targeting, preparation method and use thereof | |
CN114196702A (en) | Method for constructing long QT disease stem cells by using single-base editor | |
CN107400679A (en) | Plasmid vector and its application for being overexpressed stability series are established based on transposase | |
CN109371058A (en) | A kind of method for building up of poplar plastid expression system | |
CN111394384B (en) | Biosensor for detecting S-adenosylmethionine and preparation method thereof | |
KR102096282B1 (en) | Method for effective purification of human TREM2 proteins using recombinant baculovirus | |
US6781044B2 (en) | Plant selectable marker and plant transformation method | |
Maeda et al. | Molecular genetic characterization of Fusarium graminearum genes identified as encoding a precocene II-binding protein | |
KR102349954B1 (en) | Yeast having a improved product productivity and method of producint the product | |
CN103952407A (en) | GAL1 promoter relieving glucose inhibiting effect and application thereof | |
CN114773441B (en) | Application of Hot1p as positive control factor in improving protein expression in host cell |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |